Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Taner Coşkuner, Şengül Çağlayan, Özlem Akgün, Rüya Torun, Emine Nur Sunar Yayla, İ̇lknur Bagrul, Gülşah Kılbaş, Gülçin Otar Yener, Hülya Köse, Kübra Öztürk, Özge Baba, Mustafa Çakan, Ferhat Demir, Hafize Emine Sönmez, Mukaddes Kalyoncu, Sara Sebnem Kılıç, Selçuk Yüksel, Esra Bağlan, Sevcan A Bakkaloğlu, Erbil Ünsal, Nuray Aktay Ayaz & Betül Sözeri. (2023) The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study. Expert Opinion on Biological Therapy 0:0, pages 1-8.
Read now
Read now
Mark Kacar, Sinisa Savic & Jeroen C H van der Hilst. (2020) The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature. Journal of Inflammation Research 13, pages 141-149.
Read now
Read now
Özkan Varan, Hamit Kucuk, Hakan Babaoglu, Serdar Can Guven, Mehmet Akif Ozturk, Seminur Haznedaroglu, Berna Goker & Abdurrahman Tufan. (2019) Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis. Modern Rheumatology 29:2, pages 363-366.
Read now
Read now
Huri Ozdogan & Serdal Ugurlu. (2017) Canakinumab for the treatment of familial Mediterranean fever. Expert Review of Clinical Immunology 13:5, pages 393-404.
Read now
Read now
Articles from other publishers (23)
Elif Arslanoglu Aydin, Esra Baglan, Nesibe Gokce Kocamaz, İlknur Bagrul, Serife Tuncez & Semanur Ozdel. (2023) The effect of canakinumab treatment on growth parameters in children with familial Mediterranean fever. Clinical Rheumatology.
Crossref
Crossref
Eitan Giat, Ilan Ben-Zvi, Merav Lidar & Avi Livneh. (2022) The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease. International Journal of Molecular Sciences 23:7, pages 3956.
Crossref
Crossref
Yusuf Karabulut, Halise Hande Gezer & Mehmet Tuncay Duruöz. (2021) Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment. Rheumatology International 42:1, pages 81-86.
Crossref
Crossref
Ahmet Omma, Berkan Armaǧan, Serdar Can Güven, Sevinç Can Sandıkçı, Seda Çolak, Çiǧdem Yücel, Orhan Küçükşahin & Abdulsamet Erden. (2021) Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?. Frontiers in Pediatrics 9.
Crossref
Crossref
Caroline Vinit, Sophie Georgin-Lavialle, Aikaterini Theodoropoulou, Catherine Barbier, Alexandre Belot, Manel Mejbri, Pascal Pillet, Jana Pachlopnik, Sylvaine Poignant, Charlotte Rebelle, Andreas Woerner, Isabelle Koné-Paut & Véronique Hentgen. (2021) Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review. Frontiers in Immunology 12.
Crossref
Crossref
Tolga Yildirim, Rahmi Yilmaz, Arzu Saglam, Muge Uzerk-Kibar, Jabrayil Jabrayilov & Yunus Erdem. (2021) Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever. Nefrología (English Edition) 41:6, pages 632-639.
Crossref
Crossref
Tolga Yildirim, Rahmi Yilmaz, Arzu Saglam, Muge Uzerk-Kibar, Jabrayil Jabrayilov & Yunus Erdem. (2021) Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever. Nefrología 41:6, pages 632-639.
Crossref
Crossref
Serdal Ugurlu, Bilgesu Ergezen, Bugra Han Egeli, Oguzhan Selvi & Huri Ozdogan. (2021) Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience. Rheumatology 60:5, pages 2327-2332.
Crossref
Crossref
Hana Malcova, Zuzana Strizova, Tomas Milota, Ilja Striz, Anna Sediva, Dita Cebecauerova & Rudolf Horvath. (2021) IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives. Frontiers in Immunology 11.
Crossref
Crossref
Ali Şahin, Mehmet Emin Derin, Fatih Albayrak, Burak Karakaş & Yalçın Karagöz. (2020) Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever. Advances in Rheumatology 60:1.
Crossref
Crossref
T. Sahr, U. Kiltz, C. Weseloh, T. Kallinich & J. Braun. (2020) Ergebnisse der systematischen Literatursuche als Grundlage für die „evidenzbasierten Therapieempfehlungen für FMF-Patienten mit unzureichendem Ansprechen bzw. Unverträglichkeit auf Kolchizin“ der Gesellschaft für Kinder- und Jugendrheumatologie und der Deutschen Gesellschaft für RheumatologieResults of the systematic literature search as basis for the “Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine” of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology. Zeitschrift für Rheumatologie 79:9, pages 943-951.
Crossref
Crossref
Jasmin B Kuemmerle-Deschner, Raju Gautam, Aneesh T George, Syed Raza, Kathleen G Lomax & Peter Hur. (2020) A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever. Rheumatology 59:10, pages 2711-2724.
Crossref
Crossref
Véronique Hentgen, Caroline Vinit, Antoine Fayand & Sophie Georgin-Lavialle. (2020) The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review. Frontiers in Immunology 11.
Crossref
Crossref
Hakan Emmungil, Ufuk İlgen, Sezin Turan, Samet Yaman & Orhan Küçükşahin. (2019) Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?. Rheumatology International 40:1, pages 129-135.
Crossref
Crossref
Georges El Hasbani, Ali Jawad & Imad Uthman. (2019) Update on the management of colchicine resistant Familial Mediterranean Fever (FMF). Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
Charles Anthony Dinarello. (2019) The IL-1 family of cytokines and receptors in rheumatic diseases. Nature Reviews Rheumatology 15:10, pages 612-632.
Crossref
Crossref
Rabia Miray Kisla Ekinci, Sibel Balci, Dilek Dogruel, Derya Ufuk Altintas & Mustafa Yilmaz. (2019) Canakinumab in Children with Familial Mediterranean Fever: A Single-Center, Retrospective Analysis. Pediatric Drugs 21:5, pages 389-395.
Crossref
Crossref
Chagai Grossman, Itzhak Farberov, Olga Feld, Avi Livneh & Ilan Ben-Zvi. (2019) Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine. Rheumatology International 39:3, pages 517-523.
Crossref
Crossref
Gokhan Sargin, Reyhan Kose & Taskin Senturk. (2019) Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis. Sao Paulo Medical Journal 137:1, pages 39-44.
Crossref
Crossref
T. Kallinich, N. Blank, T. Braun, E. Feist, U. Kiltz, U. Neudorf, P. T. Oommen, C. Weseloh, H. Wittkowski & J. Braun. (2019) Evidenzbasierte Therapieempfehlungen für das familiäre MittelmeerfieberEvidence-based treatment recommendations for familial Mediterranean fever. Zeitschrift für Rheumatologie 78:1, pages 91-101.
Crossref
Crossref
Servet Akar, Pınar Cetin, Umut Kalyoncu, Omer Karadag, Ismail Sari, Muhammed Cınar, Sedat Yilmaz, Ahmet Mesut Onat, Bunyamin Kisacik, Abdulsamet Erden, Ayse Balkarli, Orhan Kucuksahin, Sibel Yilmaz Oner, Soner Senel, Abdurrahman Tufan, Haner Direskeneli, Ferhat Oksuz, Yavuz Pehlivan, Ozun Bayindir, Gokhan Keser, Kenan Aksu, Ahmet Omma, Timucin Kasifoglu, Ali Ugur Unal, Fatih Yildiz, Mehmet Ali Balci, Sule Yavuz, Sukran Erten, Metin Ozgen, Mehmet Sayarlıoglu, Atalay Dogru, Gozde Yildirim, Fatma Alibaz Oner, Mehmet Engin Tezcan, Omer Nuri Pamuk & Fatos Onen. (2018) Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients. Arthritis Care & Research 70:7, pages 1090-1094.
Crossref
Crossref
S. Georgin-Lavialle, V. Hentgen, K. Stankovic Stojanovic, C. Bachmeyer, F. Rodrigues, L. Savey, S. Abbara, P.-L. Conan, T. Fraisse, M. Delplanque, A. Rouet, N. Sbeih, I. Koné-Paut & G. Grateau. (2018) La fièvre méditerranéenne familiale. La Revue de Médecine Interne 39:4, pages 240-255.
Crossref
Crossref
Howard A. Liebman. 2018. Antibody Therapy. Antibody Therapy
85
100
.